Extractos del Sur is a Uruguayan company specialized in developing and producing medicinal cannabis extracts and oils, focused on the Brazilian market with a presence in Uruguay. We connect science, quality and people to develop effective solutions for doctors, patients and partners around the world. We operate as a technical-scientific hub between Uruguay's regulatory expertise — a world pioneer in cannabis regulation since 2013 — and the growing demand from industry and the medical community in Brazil. We run three business lines: EDS Therapeutics, our finished-product brand (www.eds.uy); B2B white-label and bulk solutions (oils, distillates, isolates and terpenes, with end-to-end development, manufacturing and logistics support for third-party brands); and high-purity active pharmaceutical ingredients (APIs) for the pharmaceutical industry and regulated markets (www.extractosdelsur.com). Through MedHub, our medical education platform, we support healthcare professionals with clinical training on cannabinoids and prescription support. Proven quality, science and innovation, and trusted partnerships are the pillars behind every stage of our work.
| Website | https://www.extractosdelsur.com/ |
| Employees | 3 (2 on RocketReach) |
| Founded | 2022 |
| Industry | Manufacturing |
Looking for a particular Extractos Del Sur employee's phone or email?
Claudio Valenti is the Co-founder and CCO of Extractos Del Sur.
2 people are employed at Extractos Del Sur.